The impact of hypoxia and its modification of the outcome of radiotherapy (Q26779537)

14 March 2019

3 April 2019

7 October 2019

on focus list of Wikimedia project

8 February 2021

ScienceSource

0 references

cites work

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Targeting hypoxia in cancer therapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Imaging hypoxia to improve radiotherapy outcome

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Modelling of the oxygen enhancement ratio for ion beam radiation therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Vascular targeted therapies in oncology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Angiogenesis and vascular targeting: relevance for hyperthermia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Hyperthermia: a potent enhancer of radiotherapy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Bioreductive drugs: from concept to clinic

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Differentiation and definition of vascular-targeted therapies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Introduction: radiosensitization by hyperthermia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

The histological structure of some human lung cancers and the possible implications for radiotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

ARCON: a novel biology-based approach in radiotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Targeting tumor blood vessels: an adjuvant strategy for radiation therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Intermittent blood flow in a murine tumor: radiobiological effects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Sensitization of hypoxic tumour cells--clinical experience

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Carbogen breathing during radiation therapy The radiation therapy oncology group study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Response of cells to hyperthermia under acute and chronic hypoxic conditions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

The Influence of Hypoxia and Acidity on the Hyperthermic Response of Malignant CellsIn Vitro

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4990104

31 May 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

Association of metformin use with cancer incidence and mortality: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJRR%2FRRW007

Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation

21 January 2018

1 reference

12 December 2020

Tumor radiosensitization through reductions in hemoglobin affinity

1 reference

12 December 2020

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

1 reference

12 December 2020

THE EFFECT OF OXYGEN ON THE RESPONSE OF SPONTANEOUS TUMOURS IN MICE TO RADIOTHERAPY

1 reference

12 December 2020

Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma

1 reference

12 December 2020

Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor

1 reference

12 December 2020

Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial

1 reference

12 December 2020

Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinoma

1 reference

12 December 2020

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

12 December 2020

Acute versus chronic hypoxia: why a simplified classification is simply not enough

1 reference

12 December 2020

Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas

1 reference

12 December 2020

Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria

1 reference

12 December 2020

Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers

1 reference

12 December 2020

Hyperthermic radiosensitization: mode of action and clinical relevance

1 reference

12 December 2020

In vitro hypoxic cytotoxicity of nitroimidazoles: uptake and cell cycle phase specificity

1 reference

12 December 2020

A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix

1 reference

12 December 2020

Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells

1 reference

12 December 2020

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

1 reference

12 December 2020

Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: long-term results of a placebo-controlled randomised study

1 reference

12 December 2020

Clinical trial with atmospheric oxygen breathing during radiotherapy of cancer of the cervix

1 reference

12 December 2020

Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro

1 reference

12 December 2020

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1 reference

12 December 2020

The oxygen dependence of the reduction of nitroimidazoles in a radiolytic model system

1 reference

12 December 2020

Measurement of tumor oxygenation

1 reference

12 December 2020